These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8906285)

  • 1. Clinical features of eosinophilia myalgia syndrome and related disorders.
    Clauw DJ
    Adv Exp Med Biol; 1996; 398():331-8. PubMed ID: 8906285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The eosinophilia-myalgia syndrome and the toxic oil syndrome. Pursuing parallels.
    Hertzman PA
    Adv Exp Med Biol; 1996; 398():339-42. PubMed ID: 8906286
    [No Abstract]   [Full Text] [Related]  

  • 3. Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia.
    Kaufman LD; Krupp LB
    Curr Opin Rheumatol; 1995 Nov; 7(6):560-7. PubMed ID: 8579979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia.
    Bolster MB; Silver RM
    Curr Opin Rheumatol; 1994 Nov; 6(6):642-9. PubMed ID: 7865387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia.
    Silver RM
    Curr Opin Rheumatol; 1992 Dec; 4(6):851-6. PubMed ID: 1457280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3-(Phenylamino)alanine--a link between eosinophilia-myalgia syndrome and toxic oil syndrome?
    Philen RM; Hill RH
    Mayo Clin Proc; 1993 Feb; 68(2):197-200. PubMed ID: 8423703
    [No Abstract]   [Full Text] [Related]  

  • 7. Pulmonary hypertension in patients with eosinophilia-myalgia syndrome or toxic oil syndrome.
    Cheng TO
    Mayo Clin Proc; 1993 Aug; 68(8):823-4. PubMed ID: 8331987
    [No Abstract]   [Full Text] [Related]  

  • 8. Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia.
    Silver RM
    Curr Opin Rheumatol; 1993 Nov; 5(6):802-8. PubMed ID: 8117543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxic oil syndrome and eosinophilia-myalgia syndrome: May 8-10, 1991, World Health Organization meeting report.
    Philen RM; Posada M
    Semin Arthritis Rheum; 1993 Oct; 23(2):104-24. PubMed ID: 8266108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Eosinophilia myalgia syndrome (EMS) caused by L-tryptophan product and toxic oil syndrome (TOS) caused by denatured rape-seed oil].
    Maitani T; Saitoh H
    Shokuhin Eiseigaku Zasshi; 2009 Dec; 50(6):279-91. PubMed ID: 20065617
    [No Abstract]   [Full Text] [Related]  

  • 11. 3-(Phenylamino)alanine, a novel aniline-derived amino acid associated with the eosinophilia-myalgia syndrome: a link to the toxic oil syndrome?
    Mayeno AN; Belongia EA; Lin F; Lundy SK; Gleich GJ
    Mayo Clin Proc; 1992 Dec; 67(12):1134-9. PubMed ID: 1469924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biotransformation of 3-(phenylamino)-1,2-propanediol to 3-(phenylamino)alanine: a chemical link between toxic oil syndrome and eosinophilia-myalgia syndrome.
    Mayeno AN; Benson LM; Naylor S; Colberg-Beers M; Puchalski JT; Gleich GJ
    Chem Res Toxicol; 1995; 8(7):911-6. PubMed ID: 8555405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical analysis of lymphocytes in postmortem study of the heart from fatal cases of the eosinophilia myalgia syndrome and of the toxic oil syndrome.
    Hayashi T; James TN
    Am Heart J; 1994 May; 127(5):1298-308. PubMed ID: 8172059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxic oil syndrome: a current clinical and epidemiologic summary, including comparisons with the eosinophilia-myalgia syndrome.
    Kilbourne EM; Posada de la Paz M; Abaitua Borda I; Diez Ruiz-Navarro M; Philen RM; Falk H
    J Am Coll Cardiol; 1991 Sep; 18(3):711-7. PubMed ID: 1869734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxic oil syndrome and eosinophilia myalgia syndrome: similar, different or the same disorder?
    Kaufman LD; Izquierdo Martinez M; Gomez-Reino JJ
    J Rheumatol; 1994 Dec; 21(12):2177-8. PubMed ID: 7699614
    [No Abstract]   [Full Text] [Related]  

  • 16. Epidemiology of the toxic oil syndrome.
    Philen RM; Posada de la Paz M; Hill RH; Schurz HH; Abaitua Borda I; Gómez de la Cámara A; Kilbourne EM
    Arch Toxicol Suppl; 1997; 19():41-52. PubMed ID: 9079193
    [No Abstract]   [Full Text] [Related]  

  • 17. Toxicologists versus toxicological disasters: toxic oil syndrome, clinical aspects.
    Gómez de la Cámara A; Abaitua Borda I; Posada de la Paz M
    Arch Toxicol Suppl; 1997; 19():31-40. PubMed ID: 9079192
    [No Abstract]   [Full Text] [Related]  

  • 18. Toxic oil syndrome: the perspective after 20 years.
    Posada de la Paz M; Philen RM; Borda AI
    Epidemiol Rev; 2001; 23(2):231-47. PubMed ID: 12192735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in tryptophan metabolism in the toxic oil syndrome and in the eosinophilia-myalgia syndrome.
    Silver RM; Sutherland SE; Carreira P; Heyes MP
    J Rheumatol; 1992 Jan; 19(1):69-73. PubMed ID: 1532618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous toxic mucinoses.
    Rongioletti F; Rebora A
    J Am Acad Dermatol; 1992 May; 26(5 Pt 1):789-90. PubMed ID: 1583189
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.